On Tuesday evening, Vinge received the award for Swedish M&A firm of the year 2023 at the Mergermarket European M&A Awards in London.
"We are incredibly happy and proud to once again receive the industry's most prestigious M&A award. Despite a challenging market characterised by great economic and geopolitical uncertainty, we have been entrusted with assisting our clients in many of the largest and most complex transactions in the Swedish market, including Thermo Fisher Scientific in its takeover bid to the shareholders of Olink, Biotage in its acquisition of Astrea Bioseparations from Gamma Biosciences, Altor in its acquisition of a minority stake in Marshall, Fyndiq in its merger with CDON, Yubico in its merger with the Swedish spac:ACQ Bure, as well as SBB on the spin-off of Neobo and the formation and financing of SBB Residential Property," says Jonas Bergström, Head of M&A at Vinge.
So far in 2023, Vinge has been engaged in more than 100 transactions with a total transaction value of approximately EUR 25 billion, which makes Vinge the firm which has the most and largest transactions on the Swedish market during the year.
"We are very grateful for the trust that our clients have placed in us during the year, and see it as an acknowledgement of the quality of our advice and the strength of our full-service concept. The ability to offer legal expertise in all areas of business law allows us to handle highly complex assignments and deliver advice of the highest quality", Jonas Bergström continues.
The jury's choice is based on both the number of transactions completed and the value of the deals. It also takes into account the strategic, complex and innovative nature of the transactions. The jury consists of M&A experts and representatives from Mergermarket.
